QSI icon

Quantum-Si Incorporated

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
Business Wire
24 days ago
Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements.
Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
Neutral
Business Wire
1 month ago
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Business Wire
1 month ago
Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Highlights Significant Development Advancements for ProteusTM and Industry Leading Technology Pipeline at Investor & Analyst Day.
Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day
Neutral
Seeking Alpha
1 month ago
Quantum-Si incorporated (QSI) Analyst/Investor Day Transcript
Quantum-Si incorporated ( QSI ) Analyst/Investor Day November 19, 2025 10:00 AM EST Company Participants Jeffrey Hawkins - President, CEO & Director Todd Rearick - Chief Technology Officer John Vieceli - Chief Product Officer Brian Reed Conference Call Participants Kyle Mikson - Canaccord Genuity Corp., Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Scott Henry - Alliance Global Partners, Research Division Puneet Souda - Leerink Partners LLC, Research Division Presentation Jeffrey Hawkins President, CEO & Director All right.
Quantum-Si incorporated (QSI) Analyst/Investor Day Transcript
Neutral
Business Wire
1 month ago
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day
BRANFORD, Conn.--(BUSINESS WIRE)--QSI to Highlight Significant Proteus™ Platform Dev Progress & Provide Insights into Company's Industry Leading Tech Pipeline at Investor & Analyst Day.
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day
Neutral
Seeking Alpha
2 months ago
Quantum-Si incorporated (QSI) Q3 2025 Earnings Call Transcript
Quantum-Si incorporated ( QSI ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Risa Lindsay Jeffrey Hawkins - President, CEO & Director Jeffry Keyes - CFO & Treasurer Conference Call Participants Alexander Vukasin - Canaccord Genuity Corp., Research Division Scott Henry - Alliance Global Partners, Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good day, and thank you for standing by.
Quantum-Si incorporated (QSI) Q3 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
2 months ago
Quantum-Si Incorporated (QSI) Reports Q3 Loss, Lags Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.17 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.18 per share a year ago.
Quantum-Si Incorporated (QSI) Reports Q3 Loss, Lags Revenue Estimates
Neutral
Business Wire
2 months ago
Quantum-Si Reports Third Quarter 2025 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Third Quarter 2025 Financial Results. Announces Successful Sequencing on Prototype Proteus Unit, Development Program is On-Track.
Quantum-Si Reports Third Quarter 2025 Financial Results
Neutral
Business Wire
2 months ago
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Neutral
Business Wire
3 months ago
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025.
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025